PHARMARON, INC Federal Contracts — Government Award History
Total (All Time)$1M
Latest FY$235,520
Primary AgencyDepartment of Health and Human Services
PHARMARON, INC has received $1M in total federal contract awards
across 4 fiscal year(s). ▼ 41.5% vs FY2023 Peak year was FY2023 ($402,670).
Primary awarding agency: Department of Health and Human Services.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2024 | $235,520 | 4건 | Department of Health and Human Services | |
| FY2023 | $402,670 | 9건 | Department of Health and Human Services | |
| FY2022 | $273,270 | 4건 | Department of Health and Human Services | |
| FY2021 | $377,880 | 7건 | Department of Health and Human Services |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2017-09-22 | Department of Health and Human Services | $281,751 | IGF::OT::IGF |
| 2023-09-01 | Department of Health and Human Services | $124,200 | EVALUATING PHARMACOKINETICS OF COMPOUNDS FROM DYSTONIA IN MICE, DOGS, RATS |
| 2022-08-09 | Department of Health and Human Services | $117,930 | EVALUATING NNMT INHIBITORS IN METABOLIC DISORDERS |
| 2021-08-11 | Department of Health and Human Services | $114,040 | EVALUATING NNMT INHIBITORS IN METABOLIC DISORDERS |
| 2023-11-28 | Department of Health and Human Services | $108,000 | PHARMACOKINETICS EXPERIMENTS, N=40, 2 ARM, RODENT |
| 2019-09-18 | Department of Health and Human Services | $102,250 | GLP STUDIES IN RATS AND DOGS |
| 2021-03-08 | Department of Health and Human Services | $78,300 | TESTING OF COMPOUNDS FOR BLOCK OF CARDIAC ION CHANNELS |
| 2021-11-17 | Department of Health and Human Services | $78,300 | TESTING OF COMPOUNDS FOR BLOCK OF CARDIAC ION CHANNELS |
| 2022-12-08 | Department of Health and Human Services | $78,300 | TESTING OF COMPOUNDS FOR BLOCK OF CARDIAC ION CHANNELS |
| 2024-03-13 | Department of Health and Human Services | $78,300 | TESTING OF COMPOUNDS IN CARDIAC ION CHANNEL ASSAYS |
| 2023-09-01 | Department of Health and Human Services | $64,090 | MAXIMALLY TOLERATED DOSE (MTD) AND 14-DAY DOSE RANGE-FINDING (DRF) TOXICITY STUD |
| 2021-08-04 | Department of Health and Human Services | $55,800 | EVALUATING PHARMACOKINETICS OF COMPOUNDS FROM DYSTONIA PROJECT; PERIOD OF PERFOR |
| 2021-02-02 | Department of Health and Human Services | $54,000 | TESTING OF COMPOUNDS IN RAT PHARMACOKINETIC EXPERIMENTS |
| 2022-05-11 | Department of Health and Human Services | $54,000 | TESTING OF COMPOUNDS IN RAT PHARMACOKINETIC STUDIES |
| 2023-09-13 | Department of Health and Human Services | $39,060 | EVALUATING ADME OF COMPOUNDS FROM DYSTONIA PROJECT |
| 2021-08-12 | Department of Health and Human Services | $35,600 | EVALUATING NNMT INHIBITORS IN HIGH GRADE SEROUS OVARIAN CANCER MOUSE MODEL |
| 2023-05-19 | Department of Health and Human Services | $26,100 | PHARMACOKINETIC STUDY (PK) AT PHARMARON USING A NOVEL POLYMERIC FORMULATION DEVE |
| 2023-05-18 | Department of Health and Human Services | $26,100 | PHARMACOKINETIC STUDY (PK) INVOLVING NCGC00413972 IN THREE DIFFERENT FORMS: (1) |
| 2024-09-18 | Department of Health and Human Services | $24,900 | PHARMARON, INC.:1208250 [24-007232] |
| 2024-09-23 | Department of Health and Human Services | $24,320 | PHARMACOKINETIC STUDIES OF TWO COMPOUNDS IN NON-NAIVE CYNOMOLGUS MONKEYS, USING |